Shortage reports
Actual shortage:
259 (8%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
3057 (92%)
3327
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
411 (94%)
Reversed:
23 (5%)
436
485 (13%)
11 (4%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-02-24 | 2022-03-09 | 155554 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2018-03-13 | 2018-07-30 | 42576 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-11-03 | 2023-12-14 | 209139 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-11-03 | 2023-12-14 | 209142 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2024-07-11 | 2025-06-13 | 232735 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2023-06-16 | 2023-07-06 | 195192 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2024-10-11 | 2025-01-09 | 240075 |
| TEVA-TRIACOMB | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2019-12-19 | 2020-04-02 | 101722 |
| TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2021-04-15 | 2021-11-18 | 137538 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 1MG 100000UNIT | CREAM | Resolved | 2025-11-20 | 2025-12-18 | 272286 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 1MG 100000UNIT | CREAM | Resolved | 2025-10-30 | 2025-12-18 | 270657 |
| TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2021-03-04 | 2021-11-18 | 135132 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2022-01-20 | 2023-07-14 | 153153 |
| TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2020-10-01 | 2020-11-07 | 125488 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2023-02-02 | 2023-07-14 | 183374 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2023-06-20 | 2023-07-06 | 195812 |
| TEVA-TRIACOMB | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2020-02-21 | 2020-04-02 | 106934 |
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Resolved | 2023-08-17 | 2023-10-12 | 202200 |
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Resolved | 2020-01-09 | 2020-02-13 | 102884 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-05-01 | 110791 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |